Michael Morrissey
Chief Executive Officer presso EXELIXIS, INC.
Patrimonio netto: 55 M $ in data 29/02/2024
Profilo
Attualmente, Michael M. Morrissey occupa la posizione di presidente, amministratore delegato e direttore di Exelixis, Inc. Il Dr. Morrissey è anche nel consiglio di amministrazione di XWPharma Ltd. Nella sua carriera passata il Dr. Morrissey ha occupato la posizione di scienziato senior presso Ciba-Geigy Corp. e di vicepresidente della ricerca di scoperta presso Berlex Biosciences. Michael M. Morrissey ha ricevuto un dottorato dalla Harvard University e una laurea presso l'Università del Wisconsin.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
EXELIXIS, INC.
0.82% | 23/02/2024 | 2 492 969 ( 0.82% ) | 55 M $ | 29/02/2024 |
10/05/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Posizioni attive di Michael Morrissey
Società | Posizione | Inizio |
---|---|---|
EXELIXIS, INC. | Chief Executive Officer | 22/07/2010 |
VERA THERAPEUTICS, INC. | Chairman | 24/05/2022 |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Director/Board Member | 16/12/2020 |
Precedenti posizioni note di Michael Morrissey
Società | Posizione | Fine |
---|---|---|
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Director/Board Member | 01/11/2022 |
Berlex Biosciences | Corporate Officer/Principal | 01/01/2000 |
Ciba-Geigy Corp. | Chief Tech/Sci/R&D Officer | 01/01/1991 |
Formazione di Michael Morrissey
Harvard University | Doctorate Degree |
University of Wisconsin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
EXELIXIS, INC. | Health Technology |
VERA THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Ciba-Geigy Corp. | Health Technology |
Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Commercial Services |